ClearPoint Neuro Inc logo

CLPT

ClearPoint Neuro Inc

$14.6

Earnings Summary

Revenue
$5.03Mn
Net Profits
$-3.96Mn
Net Profit Margins
-78.69%

Highlights

Revenue:

ClearPoint Neuro Inc’s revenue jumped 24.84% since last year same period to $5.03Mn in the Q1 2022. On a quarterly growth basis, ClearPoint Neuro Inc has generated 235.79% jump in its revenue since last 3-months.

Net Profits:

ClearPoint Neuro Inc’s net profit fell -55.99% since last year same period to $-3.96Mn in the Q1 2022. On a quarterly growth basis, ClearPoint Neuro Inc has generated 4.58% jump in its net profits since last 3-months.

Net Profit Margins:

ClearPoint Neuro Inc’s net profit margin fell -24.95% since last year same period to -78.69% in the Q1 2022. On a quarterly growth basis, ClearPoint Neuro Inc has generated -170.27% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the ClearPoint Neuro Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.18
EPS Estimate Current Year
-0.18

Highlights

EPS Estimate Current Quarter:

ClearPoint Neuro Inc’s earning per share (EPS) estimates for the current quarter stand at -0.18 - a 10% jump from last quarter’s estimates.

EPS Estimate Current Year:

ClearPoint Neuro Inc’s earning per share (EPS) estimates for the current year stand at -0.18.

Key Ratios

Key ratios of the ClearPoint Neuro Inc post its Q1 2022 earnings

Earning Per Share (EPS)
-0.17
Return on Assets (ROA)
-0.15
Return on Equity (ROE)
-0.36
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

ClearPoint Neuro Inc’s earning per share (EPS) fell -30.77% since last year same period to -0.17 in the Q1 2022. This indicates that the ClearPoint Neuro Inc has generated -30.77% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. ClearPoint Neuro Inc’s return on assets (ROA) stands at -0.15.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. ClearPoint Neuro Inc’s return on equity (ROE) stands at -0.36.

Dividend Per Share (DPS):

ClearPoint Neuro Inc declared 0 dividend per share during the earnings announcement for Q1 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-05-11
-0.2
-0.17
15%

Company Information

ClearPoint Neuro's mission is to improve and restore quality of life to patients and their families by enabling therapies for the most complex neurological disorders with pinpoint accuracy. Applications of the Company's current product portfolio include deep-brain stimulation, laser ablation, biopsy, neuro-aspiration, and delivery of drugs, biologics, and gene therapy to the brain. The ClearPoint Neuro Navigation System has FDA clearance, is CE-marked, and is installed in over 60 active clinical sites in the United States, Canada, and Europe. The Company's SmartFlow® cannula is being used in partnership or evaluation with 25 individual biologics and drug delivery companies in various stages from preclinical research to late-stage regulatory trials. To date, more than 4,000 cases have been performed and supported by the Company's field-based clinical specialist team which offers support and services for its partners.

Organisation
ClearPoint Neuro Inc
Employees
67
Industry
Health Technology